EBV and 1q Gains Affect Gene and miRNA Expression in Burkitt Lymphoma
Viruses · 2023
DOI: 10.3390/v15091808 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Nuray Akyüz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Clinic Hamburg-Eppendorf, 20251 Hamburg, Germa…. Hauptthemen laut MEDLINE: Burkitt Lymphoma, MicroRNAs, Herpesvirus 4, Human, Chromosomes, Human, Pair 1. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 205 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wilhelm Sander Foundation.
Abstract (Originalsprache)
Abnormalities of the long arm of chromosome 1 (1q) represent the most frequent secondary chromosomal aberrations in Burkitt lymphoma (BL) and are observed almost exclusively in EBV-negative BL cell lines (BL-CLs). To verify chromosomal abnormalities, we cytogenetically investigated EBV-negative BL patient material, and to elucidate the 1q gain impact on gene expression, we performed qPCR with six 1q-resident genes and analyzed miRNA expression in BL-CLs. We observed 1q aberrations in the form of duplications, inverted duplications, isodicentric chromosome idic(1)(q10), and the accumulation of 1q12 breakpoints, and we assigned 1q21.2–q32 as a commonly gained region in EBV-negative BL patients. We detected MCL1, ARNT, MLLT11, PDBXIP1, and FCRL5, and 64 miRNAs, showing EBV- and 1q-gain-dependent dysregulation in BL-CLs. We observed MCL1, MLLT11, PDBXIP1, and 1q-resident miRNAs, hsa-miR-9, hsa-miR-9*, hsa-miR-92b, hsa-miR-181a, and hsa-miR-181b, showing copy-number-dependent upregulation in BL-CLs with 1q gains. MLLT11, hsa-miR-181a, hsa-miR-181b, and hsa-miR-183 showed exclusive 1q-gains-dependent and FCRL5, hsa-miR-21, hsa-miR-155, hsa-miR-155*, hsa-miR-221, and hsa-miR-222 showed exclusive EBV-dependent upregulation. We confirmed previous data, e.g., regarding the EBV dependence of hsa-miR-17-92 cluster members, and obtained detailed information considering 1q gains in EBV-negative and EBV-positive BL-CLs. Altogether, our data provide evidence for a non-random involvement of 1q gains in BL and contribute to enlightening and understanding the EBV-negative and EBV-positive BL pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Clinic Hamburg-Eppendorf, 20251 Hamburg, Germany.
ORCID-Profile: Snjezana Janjetovic, Susanne Ghandili
Förderung
- Wilhelm Sander Foundation
Zitieren
APA
Akyüz, N., Janjetovic, S., Ghandili, S., Bokemeyer, C., & Dierlamm, J. (2023). EBV and 1q Gains Affect Gene and miRNA Expression in Burkitt Lymphoma. Viruses. https://doi.org/10.3390/v15091808
Vancouver
Akyüz N, Janjetovic S, Ghandili S, Bokemeyer C, Dierlamm J. EBV and 1q Gains Affect Gene and miRNA Expression in Burkitt Lymphoma. Viruses. 2023. doi:10.3390/v15091808
BibTeX
@article{Akyz2023,
author = {Akyüz, Nuray and Janjetovic, Snjezana and Ghandili, Susanne and Bokemeyer, Carsten and Dierlamm, Judith},
title = {EBV and 1q Gains Affect Gene and miRNA Expression in Burkitt Lymphoma},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15091808}
}
EUVIMED